The quality of our team
Harold C. Smith, Ph.D. Founder and CEO
32 years disease mechanism research, 15 years biotech drug development experience
Opinion leader in Epigenetics, 146 peer-reviewed publications
$16 M in Federal and Foundation Grant support, Bill and Melinda Gates funded Investigator
$6.8M raised as seed capital for OyaGen, Inc
Designed and established 6 laboratories since 1976 and directed operations at SUNY at Buffalo, Baylor College of Medicine, URMC Rochester and OyaGen, Inc
Charles Smith, Ph.D.
Ryan Bennett, Ph.D.
Andrew K Gonsalves,
David Yule, Ph.D.
Mitch O’Connell, Ph.D.
Gene Editing Consultant
Luke Peppone, Ph.D.
Cannabis Clinical Trials